Home / Inspections / 1247238

FDA Inspection 1247238 — Jerome Stevens Pharmaceuticals, Inc.

Jerome Stevens Pharmaceuticals, Inc. — FEI 2431950

The FDA completed an inspection of Jerome Stevens Pharmaceuticals, Inc. on August 1, 2024 in Bohemia, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 1, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bohemia, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1171967 (VAI Wed Jun 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1086248 (VAI Thu Apr 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1009653 (VAI Thu Mar 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 935880 (VAI Thu Jul 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 856030 (VAI Thu Nov 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources